Skip to content

Released Nov 17, 2014, before the open

10-Q filed Nov 17, 2014, 48 days after period end · 0001144204-14-069040

Q3 2014 · 10-Q
Revenue—
Net Income-$11.02MN/M vs Q3 2013N/M vs Q2 2014
EPS Diluted-$1.33N/M vs Q3 2013N/M vs Q2 2014
Operating Income-$11,055,440N/M
Operating Cash Flowderived-$3,875,127—
Free Cash Flowderived-$3,893,064—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2014Q3 2013Q3 2012Q3 2011
Net Income-$11.02M-$4.88M-$5.36M-$5.80M
EPS Diluted-$1.33-$1.23-$0.41-$0.50

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR